Skip to main content
Sequent Scientific Limited (NSE:SEQUENT)
India flag India · Delayed Price · Currency is INR
189.05
-0.25 (-0.13%)
Jun 10, 2025, 3:29 PM IST

Sequent Scientific Revenue

In the fiscal year ending March 31, 2025, Sequent Scientific had annual revenue of 15.51B INR with 13.26% growth. Sequent Scientific had revenue of 4.02B in the quarter ending March 31, 2025, with 11.21% growth.

Revenue
15.51B
Revenue Growth
+13.26%
P/S Ratio
3.05
Revenue / Employee
12.98M
Employees
1,195
Market Cap
47.33B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202515.51B1.82B13.26%
Mar 31, 202413.70B-511.78M-3.60%
Mar 31, 202314.21B80.93M0.57%
Mar 31, 202214.13B512.01M3.76%
Mar 31, 202113.62B1.82B15.47%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 525.78B
Divi's Laboratories 93.60B
Cipla 271.45B
Apollo Hospitals Enterprise 217.94B
Mankind Pharma 122.07B
Zydus Lifesciences 232.42B
Aurobindo Pharma 317.24B
Alkem Laboratories 129.65B
Revenue Rankings

Sequent Scientific News

More News